Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome women notice changes to their menstrual cycle after starting Wegovy. This is not unusual, and in most cases it reflects the body adjusting to significant weight loss rather than a direct pharmacological effect of semaglutide itself. Rapid changes in body fat influence the hormones that regulate ovulation and cycle length. That said, the evidence base is still developing, and a prescriber is the right person to assess anything that concerns you. Wegovy is a prescription-only medicine; suitability is decided clinically, not automatically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the question most women asking about Wegovy and menstruation actually want answered, and the honest reply is: it's mostly indirect. Semaglutide, the active ingredient in Wegovy, works by mimicking a gut hormone called GLP-1, which reduces appetite and slows how quickly the stomach empties. That mechanism does not directly target the hypothalamic-pituitary-ovarian axis, the hormonal chain that governs your cycle.
What does act on that axis is body fat. Adipose tissue is metabolically active; it produces and stores oestrogen. When you lose a meaningful amount of weight, oestrogen levels shift, and the brain's signals to the ovaries can change with them. That is why women who lose weight quickly (through any method) sometimes notice shorter, longer, heavier, lighter or skipped periods during the process. The same principle applies on Wegovy. The NHS notes that significant weight loss can affect your cycle, and the NHS semaglutide medicines page is a useful starting point for understanding the medicine's broader effects.
None of this means changes should be ignored. A missed period or a sudden shift in your cycle always warrants a conversation with a clinician. Our overview of semaglutide covers the wider pharmacology if you want more background on how the medicine works.
Yes, and this catches some women off guard. Conditions linked to higher body weight, including polycystic ovary syndrome (PCOS), can suppress ovulation. As weight falls and hormonal balance shifts, ovulation can return or become more regular. Some women who had irregular or absent periods find their cycle re-establishes itself during treatment. That is generally a positive sign for reproductive health, but it does mean fertility can increase.
If you are not planning a pregnancy, reliable contraception is essential throughout your time on Wegovy. There is an additional consideration for women on Wegovy who use the combined oral contraceptive pill: semaglutide slows gastric emptying, which could theoretically reduce absorption of oral medicines taken during that window, though the clinical evidence specifically for the pill is less clear-cut than it is for tirzepatide. NHS England recommends discussing your contraceptive method with a prescriber when starting any GLP-1 medicine, and considering a non-oral method as an added precaution if there is any doubt.
Wegovy is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive, these are firm contraindications, not caveats. If your situation changes, tell your prescriber promptly.
Honest answer: the evidence is limited and mostly observational at this stage. The large clinical trials behind Wegovy's licence (including the STEP 1 trial published in the New England Journal of Medicine) were designed to measure weight loss and cardiovascular outcomes, not reproductive function. Menstrual changes were not a primary endpoint, so they were not systematically tracked.
What clinicians do have is a solid understanding of how weight loss affects the reproductive axis, and the emerging real-world picture from women who have used GLP-1 medicines. The pattern reported most often is irregular cycles in the early months of treatment, which tend to settle as weight loss slows and the body reaches a new equilibrium. Heavier periods have also been noted anecdotally, again possibly reflecting hormonal recalibration. If you are curious about the specific question of how semaglutide may interact with cycle timing, our page on whether Wegovy can affect your menstrual cycle goes deeper into the mechanisms.
One thing worth knowing: the question of whether Wegovy interferes with the menstrual cycle is distinct from whether it interferes with contraception. These are two separate clinical conversations, and collapsing them can lead to unnecessary anxiety about one and insufficient caution about the other.
Most cycle changes on Wegovy resolve without any intervention, but some warrant prompt attention. Speak to a GP or your prescriber if you experience: a missed period and any possibility of pregnancy; bleeding that is unusually heavy or lasts significantly longer than normal; severe pelvic pain alongside any change in your cycle; or cycle disruption that persists beyond three to four months with no sign of stabilising.
If you are taking Wegovy and also have a condition such as PCOS, endometriosis, or a thyroid disorder, changes to your cycle deserve closer monitoring because the picture is more complex. Don't hesitate to use our support line, our team are available seven days a week.
For women thinking about starting treatment and wondering how to get a prescription, our page on weight-loss treatment options explains the licensed routes. If you are already curious about what treatment costs and what is included, our Wegovy cost page covers the private pricing context honestly. And if you have practical questions about injecting correctly (which matters for consistent absorption) administration guidance is worth reading before your first dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.